Hvad er Org-nummeret på Tigen Pharma (Sweden) AB?

Tigen Pharma (Sweden) AB er registreret hos Bolagsverket / SCB under Org 5593325060.

Hvem er administrerende direktør i Tigen Pharma (Sweden) AB?

Matthias Pannier er Authorized Recipient of Service i Tigen Pharma (Sweden) AB, i rollen siden 2022.

Hvem er bestyrelsesformand i Tigen Pharma (Sweden) AB?

Hans Jarl Rutger Arnhult er bestyrelsesformand i Tigen Pharma (Sweden) AB, i rollen siden 2021.

Hvor har Tigen Pharma (Sweden) AB hovedsæde?

Tigen Pharma (Sweden) ABs registrerede adresse er Stockholm.

Riskpilot← Tilbage til søgning

Log indFå fuld adgang

Tigen Pharma (Sweden) AB

ABActive

Org 5593325060StockholmResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20210 employees

Overview Financials People & ownership Related companies

Financials

Revenue

SEK millions

EBITDA

SEK millions

Income statement

SEK thousands

Item	2022	2023	2024
Revenue	0	0	0
Staff expenses	—	—	—
EBITDA	−96	−56	−42
Depreciation & amort.	−0	−0	−0
EBIT	−96	−56	−42
Net financials	—	—	—
Profit before tax	−96	−56	−42
Tax	−0	−0	−0
Net profit	−96	−56	−42

Balance sheet

SEK thousands

Item	2022	2023	2024
Total assets	312	294	340
Equity	179	123	81
Long-term debt	76	158	186
Short-term debt	57	13	72
Total debt	133	171	258

Financial ratios

5-year trend

EBITDA-margin

-4200000.0%

This company

15.8%

Market median

-26582378% vs market

20222024

Soliditetsgrad

23.8%

This company

38.2%

Market median

-38% vs market

20222024

Egenkapitalforrentning

-51.9%

This company

18.4%

Market median

-382% vs market

20222024

Nettoresultatgrad

-4200000.0%

This company

8.1%

Market median

-51851952% vs market

20222024

Aktivomsætning

0.00×

This company

1.12×

Market median

-100% vs market

20222024

Gæld/egenkapital

3.20×

This company

0.62×

Market median

-416% vs market

20222024

Annual reports & filings

Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-08-01 – 2022-12-31
View PDF

Tigen Pharma (Sweden) AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Tigen Pharma (Sweden) AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Tigen Pharma (Sweden) AB